live.euronext1d
Welcome to Euronext Live
The new Euronext websites are now live. They replace the former Euronext.com and its related multiple add-on sites with three new, clearly-defined websites: Explore Euronext.com to find out more about ...
live.euronext2d
Oslo Børs
13:46 CET Spotlio AS - Notice of an Extraordinary General Meeting ...
live.euronext3d
ZITON A/S - interim report Q4 2024
• EBITDA amounted to EUR 8.6m in Q4 2024 compared to EUR 6.2m in Q4 2023, an increase of 38%. The improvement was due to an increase in revenue reflecting that J/U WIND ENERGY went on time charter ...
live.euronext4d
Proposed Combination of Saipem and Subsea7
would enhance value for shareholders, and all stakeholders, both in the current market and in the long term. CDP Equity, Eni and Siem Industries have entered into a separate Memorandum of ...
live.euronext5d
RÉSULTATS ANNUELS 2023 - Forte amélioration du résultat opérationnel consolidé en 2023
Le Groupe présente un chiffre d’affaires de 86,6 M€ contre 84,7 M€ en 2022, cette progression (1,9 M€) s’explique principalement par la forte progression d’AMG Guyane malgré une diminution ...
live.euronext6d
Aker BioMarine ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program
controls 1,095,837 shares in the Company. - Katrine Klaveness, CFO, has subscribed for 879 new shares in the Company for a total subscription amount of NOK 47 958. Following the subscription, ...
live.euronext6d
AKBM – Offer under Employee Share Purchase Program and share capital increase
Aker BioMarine ASA (the "Company") has renewed its offer of new shares to employees in the Company and its Norwegian subsidiaries on similar terms as for the last 3 previous years (the "Employee Share ...
live.euronext6d
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different doses New endpoints presented include findings on ...
live.euronext6d
Gecina: Conditions for Accessing the 2024 Universal Registration Document
The Universal Registration Document for 2024 was filed with the French securities regulator (Autorité des marchés financiers, AMF) on February 21, 2025. It may be consulted on or downloaded from the ...
live.euronext6d
Gecina : Modalités de mise à disposition ou de consultation du Document d’enregistrement universel 2024
Le Document d’enregistrement universel 2024 a été déposé auprès de l'Autorité des marchés financiers (AMF) le 21 février 2025. - par courrier : Gecina – 16, rue des Capucines 75002 PARIS ; - par mail ...
live.euronext6d
SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program
20/02/2025 00:00:00 0 n.a. n.a. 21/02/2025 00:00:00 0 n.a. n.a. Previously disclosed buy-backs 0 n.a. n.a.
live.euronext6d
CA 2024
Chiffre d'affaires 4ème trimestre 2024 stable : 18,9 m€. Chiffre d'affaires 2024 : 75,5 m€ (- 12,53 %). La tendance baissière de ce quatrième trimestre reste alignée à celle du trimestres précedent ; ...